Fundamental analysis by اعتماد مارکت about Stock دپارس on 7/14/2025

#Assembly #Depars 📌 According to the report of the conscious voice; The annual general meeting of Pars Daru Company was held with the participation of the shareholders. The most important points in this session are as follows: In year 2, Pars Daru product basket had a major flaw; The life of its products was the same as the domestic product. In year 6, with the completion of the raw materials, the basket improved and became more complete. In the past, the company had a 6 -month -old aspirin depot, which was difficult to sell. Fortunately, this warehouse has now declined to two months. It will be prevented from reducing the company's discounts this year, thereby improving the net profit margin. The company used by the company is supplied at a rate of 4 USD, but part of it is purchased at preferential rates (close to the free market). The receipt of the claims within the group is 2 days and outside the group 2 days. Tipico Company has announced that Pars Drug sales policy is based on the interests of the company. Customer needs are reviewed and met by re -reading sessions. In year 4, the company was able to fully supply the raw materials needed for drug production. There was no important product in the market that Pars Drug did not produce. این The destruction of the distributors has been due to the lack of liquidity in the company. At the end of the assembly, 2 % of the company's profits, equivalent to 2 Rials per share, were divided among shareholders.